Too Few Prostate Cancer Patients Get Bone-Strengthening Meds: Study

December 2, 2014 10:19 PM

1 0

TUESDAY, Dec. 2, 2014 (HealthDay News) -- Many men on hormone therapy for prostate cancer aren't getting bone-strengthening drugs they may need, new Canadian research contends.

Hormone therapy, which suppresses male hormones called androgens, helps stop cancer cells from growing. But one consequence of the treatment is weakening of the bones, which can lead to fractures. To reduce this risk, men can be given oral bisphosphonates, such as Fosamax, or an intravenous treatmen...

Read more

To category page